Review
Therapy of acute myeloid leukemia in children
Affiliations
- PMID: 1578938
Item in Clipboard
Review
Therapy of acute myeloid leukemia in children
Leukemia.
1992.
Abstract
The survival of children with acute myeloid leukemia has improved with the identification of active chemotherapeutic agents and intensification of the post remission therapy using intensive chemotherapy early in the therapy. Other reports in this symposium will report equally good results with intensification early in the treatment using bone marrow transplantation. Additional factors such as long term complications and cost will become important variables to be considered, when considering the appropriate treatment for children with acute myeloid leukemia.
Similar articles
-
The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).Leukemia. 1992;6 Suppl 2:52-4. Leukemia. 1992. PMID: 1578941 Clinical Trial. No abstract available.
-
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.Pediatr Blood Cancer. 2007 Aug;49(2):127-32. doi: 10.1002/pbc.20944. Pediatr Blood Cancer. 2007. PMID: 16807916 Clinical Trial.
-
Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.Semin Oncol. 1993 Dec;20(6 Suppl 8):34-8. Semin Oncol. 1993. PMID: 8290970 Clinical Trial.
-
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.Hematol Oncol Clin North Am. 1993 Feb;7(1):47-64. Hematol Oncol Clin North Am. 1993. PMID: 8449864 Review.
-
Treatment of childhood acute myeloid leukemia.Expert Rev Anticancer Ther. 2005 Oct;5(5):917-29. doi: 10.1586/14737140.5.5.917. Expert Rev Anticancer Ther. 2005. PMID: 16221060 Review.
Cited by
-
Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.Pediatr Blood Cancer. 2014 Apr;61(4):729-36. doi: 10.1002/pbc.24881. Epub 2013 Nov 27. Pediatr Blood Cancer. 2014. PMID: 24285698 Free PMC article.
-
Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.J Pediatr Hematol Oncol. 2017 Jan;39(1):20-25. doi: 10.1097/MPH.0000000000000707. J Pediatr Hematol Oncol. 2017. PMID: 27906794 Free PMC article.